Conner EM, Grisham MB, Elsevier Inc
Current protocols come from animal research, practitioner experience, and real-world use
J., and Lake, B
Most of these therapeutic approaches require further investigation in large-scale, blinded, placebo-controlled randomised studies to achieve adequate evidence-based and clinically reliable recommendation grades [476-481]
154 Therefore, for cancers with p53 aggregates, the development and exploration of molecules that can stabilize the folded structure, suppress aggregation, or disrupt the formation of aggregates are of considerable therapeutic interest
Having access to real-world protocol data alongside the clinical guidelines makes the difference between following a generic chart and optimizing a protocol that works for your specific body and goals